Principal Investigator
Henry Moore
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220252
Clinical Trial Summary
Real-World Utilization of Deutetrabenazine Initiated by a 4-week Patient Titration Kit.
Phase
Phase IV
Funding Agency/Sponsor
Industry
Disease
Movement Disorders
Contact Information
Study Contact
Wilfredo Rodriguez Somoza
Phone Number
+1 (561) 9394169
Email
wxr205@miami.edu